Skip to main content
Poltreg S.A. logo

Poltreg S.A. — Investor Relations & Filings

Ticker · PTG ISIN · PLPLTRG00038 LEI · 259400XSAJTERJ42VZ86 WAR Professional, scientific and technical activities
Open in API
Filings indexed 359 across all filing types
Latest filing 2025-05-20 Declaration of Voting R…
Country PL Poland
Listing WAR PTG

About Poltreg S.A.

https://poltreg.com/

Poltreg S.A. is a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases. The company specializes in treatments based on T-regulatory cells (Tregs), with an advanced pipeline of both polyclonal and engineered cell therapies. Its lead product, PTG-007, is an autologous Treg treatment being investigated for Type 1 Diabetes and Multiple Sclerosis. Poltreg is also advancing next-generation engineered therapies, including Chimeric Antigen Receptor T-regulatory cells (CAR-Tregs), for neuroinflammatory conditions such as Multiple Sclerosis and Amyotrophic Lateral Sclerosis (ALS). The company operates its own state-of-the-art, cGMP-certified manufacturing facility to produce its advanced therapy medicinal products.

Recent filings

Filing Released Lang Actions
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie PolTREG S.A. w dniu 20 maja 2025 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document text is very short (587 characters) and explicitly states that the Management Board ('Zarząd') is 'attaching the content of the resolutions adopted during the Ordinary General Meeting' ('przekazuje w załączeniu treść uchwał podjętych podczas obrad Zwyczajnego Walnego Zgromadzenia Spółki'). This indicates the document itself is an announcement about the results of the AGM, rather than the full minutes or the AGM presentation itself. Since it details the resolutions passed at the General Meeting, the most appropriate classification is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). It is not a general AGM presentation (AGM-R) but the outcome of the voting.
2025-05-20 Polish
Warunkowe przyznanie patentu przez Japoński Urząd Patentowy w projekcie terapii opartych na CAR-TREG w leczeniu chorób neurodegeneracyjnych - Content (PL)
Regulatory Filings Classification · 100% confidence The document text is a short announcement (1429 characters) written in Polish, referencing a previous report ('raport bieżący 5/2021') and detailing a specific corporate event: the conditional granting of a patent by the Japanese Patent Office for a therapy ('CAR-TREG'). It discusses the implications for the company (PolTREG S.A.) and mentions future actions (paying an administrative fee) or potential future reports ('poinformuje trybie odrębnego raportu bieżącego'). This structure—a brief update on a specific, non-financial, non-shareholder meeting event that is regulatory in nature but doesn't fit the specific categories like DIRS, DIV, or CAP—points towards a general regulatory announcement. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for miscellaneous, non-standard regulatory updates that are not explicitly defined elsewhere, especially since it is a short communication about an external regulatory decision (patent grant). It is not an Earnings Release (ER), Interim Report (IR), or a specific legal/director/capital event.
2025-05-19 Polish
CV
Board/Management Information Classification · 95% confidence The document text appears to be a curriculum vitae (CV) or a professional profile listing the career history, board memberships, and roles of an individual, specifically mentioning roles in supervisory boards ("w radach nadzorczych") and various companies (e.g., EMC Instytut Medyczny SA, PKP Cargo SA, Medicalgorithmics SA). This type of document details management structure and governance roles within companies. Based on the provided definitions, the most fitting category for information detailing board composition and management roles is 'Board/Management Information' (MANG). It is not a formal regulatory filing like a 10-K, an earnings release, or a specific legal notice, but rather biographical information about a key person.
2025-05-19 Polish
Zgłoszenie kandydata na Członka Rady Nadzorczej PolTREG S.A. - Content (PL)
Board/Management Information Classification · 98% confidence The document announces that the company received a nomination from a shareholder (Allianz Polska Otwarty Fundusz Emerytalny) for a candidate (Michał Wnorowski) to the Supervisory Board (Rada Nadzorcza) ahead of the Annual General Meeting (Zwyczajnym Walnym Zgromadzeniem Spółki) scheduled for May 20, 2025. It explicitly states that the candidate's CV ('Życiorys zawodowy') is attached as an appendix to the report. This content relates directly to the composition of the board and management structure, specifically concerning nominations for the Supervisory Board. This aligns best with the 'Board/Management Information' category (MANG), which covers announcements of changes in the board of directors or senior management, including nominations for such roles. It is not a full AGM presentation (AGM-R) or a proxy statement (PSI), but a specific announcement about a board candidate.
2025-05-19 Polish
Warunkowe przyznanie patentu przez Japoński Urząd Patentowy w projekcie terapii opartych na CAR-TREG w leczeniu chorób neurodegeneracyjnych
Regulatory Filings Classification · 100% confidence The document text is a formal announcement from a Polish company (PolTREG S.A.) regarding a patent decision in Japan concerning its CAR-TREG therapy. It references previous current reports ('raport bieżący') and details a specific development (patent grant condition). This type of specific, material, non-financial update that doesn't fit into standard financial reports (10-K, IR, ER) or management changes (MANG) is best classified as a general Regulatory Filing (RNS) or potentially a Legal/IP update. Given the focus on a patent grant, it relates to intellectual property and regulatory milestones. Since 'IP' (Intellectual Property) is not an explicit option, and 'LTR' (Legal Proceedings Report) is usually for lawsuits, the most appropriate general category for significant regulatory/IP milestones that are not standard financial disclosures is RNS (Regulatory Filings), which serves as the fallback for miscellaneous regulatory announcements.
2025-05-18 Polish
Raport kwartalny 1Q 2025
Interim / Quarterly Report Classification · 100% confidence The document is explicitly titled 'Kwartalny raport finansowy' (Quarterly Financial Report) for the first quarter of 2025. It contains a detailed table of contents covering financial statements (balance sheet, cash flow, income statement), accounting policies, and management notes. As it is a comprehensive financial report for a period shorter than a full fiscal year, it fits the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-14 Polish

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.